ES2498091T3 - Procedimiento para producir nanopartículas - Google Patents
Procedimiento para producir nanopartículas Download PDFInfo
- Publication number
- ES2498091T3 ES2498091T3 ES09739571.9T ES09739571T ES2498091T3 ES 2498091 T3 ES2498091 T3 ES 2498091T3 ES 09739571 T ES09739571 T ES 09739571T ES 2498091 T3 ES2498091 T3 ES 2498091T3
- Authority
- ES
- Spain
- Prior art keywords
- nanoparticles
- procedure
- biodegradable polymer
- produce nanoparticles
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
- C08J3/14—Powdering or granulating by precipitation from solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2300/00—Characterised by the use of unspecified polymers
- C08J2300/16—Biodegradable polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2367/00—Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
- C08J2367/04—Polyesters derived from hydroxy carboxylic acids, e.g. lactones
Abstract
Método de formación de nanopartículas que comprende poner en contacto un primer líquido que comprende un polímero biodegradable disuelto en un disolvente orgánico con un segundo líquido que comprende un disolvente acuoso que comprende un tampón, que es miscible con el disolvente orgánico, al tiempo que es un no disolvente para el polímero biodegradable, en condiciones de agitación suave sin remover de manera que se forman nanopartículas, con lo que el rendimiento del proceso, en base a la cantidad de polímero biodegradable que se recupera en forma de nanopartículas, es del 90% o más y con lo que el valor D(v, 0,5) para las nanopartículas es inferior a 200 nm.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4842808P | 2008-04-28 | 2008-04-28 | |
US48428P | 2008-04-28 | ||
PCT/US2009/041932 WO2009134769A1 (en) | 2008-04-28 | 2009-04-28 | Nanoparticles for use in pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2498091T3 true ES2498091T3 (es) | 2014-09-24 |
Family
ID=40792578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES09739571.9T Active ES2498091T3 (es) | 2008-04-28 | 2009-04-28 | Procedimiento para producir nanopartículas |
Country Status (6)
Country | Link |
---|---|
US (1) | US9393295B2 (es) |
EP (1) | EP2282771B1 (es) |
JP (2) | JP2011518885A (es) |
CA (1) | CA2722765C (es) |
ES (1) | ES2498091T3 (es) |
WO (1) | WO2009134769A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100160368A1 (en) | 2008-08-18 | 2010-06-24 | Gregory Jefferson J | Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy |
MX2011001555A (es) | 2008-12-19 | 2011-04-14 | Graceway Pharmaceuticals Llc | Formulaciones de imiquimod de baja concentracion de dosis y regimenes de dosis de corta duracion para tratar queratosis actinica. |
EP2453747B1 (en) * | 2009-07-13 | 2017-08-30 | Medicis Pharmaceutical Corporation | Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts |
WO2011093043A1 (ja) * | 2010-01-27 | 2011-08-04 | 国立大学法人北海道大学 | 回折顕微法 |
WO2012164480A1 (en) * | 2011-05-30 | 2012-12-06 | National Institute Of Immunology | A vaccine composition capable of inducing memory antibody response from single point immunization |
WO2012169518A1 (ja) * | 2011-06-07 | 2012-12-13 | ホソカワミクロン株式会社 | 液状組成物及びそれを用いた化粧料並びに育毛剤 |
US20130122106A1 (en) * | 2011-10-19 | 2013-05-16 | Aphios Corporation | Dosage form, and methods of making and using the same, to produce immunization in animals and humans |
CN109876139A (zh) * | 2012-04-24 | 2019-06-14 | 俄亥俄州国家创新基金会 | 用于治疗和预防猪繁殖与呼吸综合征的组合物和方法 |
KR101732760B1 (ko) * | 2013-10-10 | 2017-05-24 | 주식회사 엘지화학 | 폴리락트산 입자의 제조방법 |
US10280199B2 (en) | 2014-02-07 | 2019-05-07 | Phibro Animal Health Corporation | Coronavirus proteins and antigens |
US10117886B2 (en) * | 2014-05-30 | 2018-11-06 | Hao Cheng | Hyaluronidase and a low density second PEG layer on the surface of therapeutic-encapsulated nanoparticles to enhance nanoparticle diffusion and circulation |
WO2017196318A1 (en) * | 2016-05-11 | 2017-11-16 | Phibro Animal Health Corporation | A composition comprising antigens and a mucosal adjuvant and a method for using |
US10279031B2 (en) | 2016-05-11 | 2019-05-07 | Phibro Animal Health Corporation | Composition comprising antigens and a mucosal adjuvant and a method for using |
WO2018009672A1 (en) | 2016-07-06 | 2018-01-11 | University Of Maryland, College Park | Polyphosphazene polyelectrolytes and uses thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0829246B2 (ja) * | 1986-10-01 | 1996-03-27 | 三菱製紙株式会社 | マイクロカプセルの製造方法 |
FR2608988B1 (fr) | 1986-12-31 | 1991-01-11 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules |
FR2634397B2 (fr) | 1986-12-31 | 1991-04-19 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une proteine sous forme de nanoparticules |
FR2608942B1 (fr) | 1986-12-31 | 1991-01-11 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules |
ATE252894T1 (de) | 1995-01-05 | 2003-11-15 | Univ Michigan | Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung |
GB9514285D0 (en) | 1995-07-13 | 1995-09-13 | Univ Nottingham | Polymeric lamellar substrate particles for drug delivery |
US6143211A (en) * | 1995-07-21 | 2000-11-07 | Brown University Foundation | Process for preparing microparticles through phase inversion phenomena |
US6884435B1 (en) | 1997-01-30 | 2005-04-26 | Chiron Corporation | Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
PT1100468E (pt) | 1998-07-29 | 2006-07-31 | Chiron Corp | Microparticulas com superficies adsorventes, processos de fabrico e utilizacao das mesmas |
CA2420621C (en) | 2000-09-28 | 2011-05-24 | Chiron Corporation | Microparticle compositions and methods for the manufacture thereof |
CA2421683C (en) | 2000-09-28 | 2009-09-15 | Chiron Corporation | Microparticles for delivery of the heterologous nucleic acids |
WO2004065578A2 (en) * | 2003-01-14 | 2004-08-05 | Chiron Corporation | Microparticles comprising polynucleotide adsorbed on the surface of or entrapped within the microparticles |
US9393215B2 (en) * | 2005-12-02 | 2016-07-19 | Novartis Ag | Nanoparticles for use in immunogenic compositions |
AU2007221154A1 (en) * | 2006-02-24 | 2007-09-07 | Novartis Ag | Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions |
PT2644594T (pt) * | 2007-09-28 | 2017-11-20 | Pfizer | Direcionamento a células cancerosas utilizando nanopartículas |
-
2009
- 2009-04-28 JP JP2011507573A patent/JP2011518885A/ja not_active Withdrawn
- 2009-04-28 US US12/990,110 patent/US9393295B2/en active Active
- 2009-04-28 CA CA2722765A patent/CA2722765C/en not_active Expired - Fee Related
- 2009-04-28 WO PCT/US2009/041932 patent/WO2009134769A1/en active Application Filing
- 2009-04-28 EP EP09739571.9A patent/EP2282771B1/en active Active
- 2009-04-28 ES ES09739571.9T patent/ES2498091T3/es active Active
-
2014
- 2014-12-22 JP JP2014258339A patent/JP2015057444A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2722765A1 (en) | 2009-11-05 |
EP2282771B1 (en) | 2014-06-25 |
US9393295B2 (en) | 2016-07-19 |
CA2722765C (en) | 2016-10-04 |
JP2011518885A (ja) | 2011-06-30 |
US20110038900A1 (en) | 2011-02-17 |
WO2009134769A1 (en) | 2009-11-05 |
EP2282771A1 (en) | 2011-02-16 |
JP2015057444A (ja) | 2015-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2498091T3 (es) | Procedimiento para producir nanopartículas | |
ES2525879T3 (es) | Procedimiento, aparato y sistema para la limpieza basada en dos disolventes de componentes de precisión | |
EA201270354A1 (ru) | Полимерные добавки для расширения технических возможностей технологических жидкостей, содержащих вязкоупругие пав, и способы их применения | |
BR112012026492A8 (pt) | Método e aparelho para processamento de deslocamento adaptativo de dados de vídeo e método e aparelho para decodificar uma corrente de bits de vídeo | |
BR112014009433A2 (pt) | processo de transformação adaptava com base em previsão em tela e aparelho usando o processo | |
BRPI0923266A8 (pt) | método para recuperação avançada de petróleo | |
SV2009003331A (es) | Palanca operativa de pivote flotante con generador | |
CL2011001992A1 (es) | Proceso para producir 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina que comprende la etapa de precipitar el solvato isopropanol bromhidrato del compuesto a partir de un solvente con mas de 65% (v/v) de isopropanol; proceso de purificacion; y el intermediario solvato isopropanol bromhidrato del compuesto. | |
AR088697A1 (es) | Procesos basados en membranas para reducir al menos una impureza y para elaborar un concentrado que comprende al menos un componente natural a partir de una mezcla de aceites de acidos grasos no marinos, y composiciones resultantes | |
CL2008000156A1 (es) | Gel estable hidrofilo en base a un polimero para aplicacion topica porque comprende quitosano disuelto en un solvente; proceso para obtener el gel para uso topico antes mencionado; uso del gel. | |
AR074022A1 (es) | Proceso de seleccion de formulacion de color con pantalla de visualizacion | |
AR097350A1 (es) | Modificadores de movilidad de fluidos para mejorar la producción en formaciones subterráneas | |
CL2011000557A1 (es) | Un proceso de alta recuperacion para la remocion de sulfato a partir de una fuente de agua; y un proceso de alta recuperacion para la remocion de sulfato y cot a partir de una fuente de agua | |
CL2012000401A1 (es) | Metodo para hacer una composicion para producir un recubrimiento ultrahidrofobo que comprende combinar un primer solvente y las particulas las cuales no son solubles pero dispersables en primer solvente y combinar con segundo solvente, obtener composicion y recuperacion de la composicion; recubrimiento ultrahidrofobo; y composicion. | |
BR112015018716A2 (pt) | técnicas para autenticar um dispositivo para encaixe sem fio | |
AR070689A1 (es) | Un procedimiento para el revestimiento de superficies metalicas con una composicion lubricante que contiene ceras | |
AR074637A1 (es) | Formas de sal de adicion acida de r-(+)-n-propargil-1-aminoindano (es decir , base de rasagilina), un compuesto de formula (1), procesos para prepararlos y aislarlos y usos de los mismos | |
AR087198A1 (es) | Composiciones de prolamina a base de agua, metodos para fabricar composiciones de prolamina a base de agua, y sus aplicaciones | |
AR072359A1 (es) | Encapsulacion de agentes biologicamente activos | |
MY194681A (en) | Chemically amplified positive type photoresist composition and pattern forming method using the same | |
EP3246663A3 (en) | Sharing safety driving metrics for navigable segments | |
EP4296340A3 (en) | Solvent application in bottle wash using amidine based formulas | |
DOP2007000025A (es) | Sistema y metodo para la separación de soluto de una solucion acuosa | |
ES2621366T3 (es) | Utilización de múltiples soplados de barra de estiramiento contrario y/o elemento de levantamiento de base | |
BRPI1006372A2 (pt) | método para analisar um fluido de amostra que contém micro-objetos orgânicos e aparelho ou sistema para analisar um fluido de amostra contendo micro-objetos orgânicos |